[go: up one dir, main page]

EP1901718A4 - MODIFIED DIFFUSION TICLOPIDINE COMPOSITIONS - Google Patents

MODIFIED DIFFUSION TICLOPIDINE COMPOSITIONS

Info

Publication number
EP1901718A4
EP1901718A4 EP06772777A EP06772777A EP1901718A4 EP 1901718 A4 EP1901718 A4 EP 1901718A4 EP 06772777 A EP06772777 A EP 06772777A EP 06772777 A EP06772777 A EP 06772777A EP 1901718 A4 EP1901718 A4 EP 1901718A4
Authority
EP
European Patent Office
Prior art keywords
ticlopidine
compositions
modified diffusion
diffusion
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06772777A
Other languages
German (de)
French (fr)
Other versions
EP1901718A1 (en
Inventor
Gary Liversidge
Scott Jenkins
Paul Stark
Niall Fanning
Gurvinder Rekhi
John Devane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perrigo Pharma International DAC
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/372,857 external-priority patent/US20060240105A1/en
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of EP1901718A1 publication Critical patent/EP1901718A1/en
Publication of EP1901718A4 publication Critical patent/EP1901718A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06772777A 2005-06-13 2006-06-09 MODIFIED DIFFUSION TICLOPIDINE COMPOSITIONS Withdrawn EP1901718A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68993105P 2005-06-13 2005-06-13
US11/372,857 US20060240105A1 (en) 1998-11-02 2006-03-10 Multiparticulate modified release composition
PCT/US2006/022597 WO2007011473A1 (en) 2005-06-12 2006-06-09 Modified release ticlopidine compositions

Publications (2)

Publication Number Publication Date
EP1901718A1 EP1901718A1 (en) 2008-03-26
EP1901718A4 true EP1901718A4 (en) 2012-07-18

Family

ID=37670856

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06772777A Withdrawn EP1901718A4 (en) 2005-06-13 2006-06-09 MODIFIED DIFFUSION TICLOPIDINE COMPOSITIONS

Country Status (5)

Country Link
EP (1) EP1901718A4 (en)
CA (1) CA2611938A1 (en)
DE (1) DE112006001548T5 (en)
ES (1) ES2326251B1 (en)
WO (1) WO2007011473A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2120878T3 (en) * 2007-02-09 2014-11-03 Alphapharm Pty Ltd Dosage form containing two active pharmaceutical ingredients in different physical forms
EP2137182A1 (en) * 2007-03-16 2009-12-30 Elan Pharma International Limited Combination of a narcotic and a non-narcotic analgesic
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3731821A1 (en) * 2017-12-29 2020-11-04 Laxxon Medical AG Drug delivery system
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051141A (en) * 1973-02-01 1977-09-27 Centre D'etudes Pour L'industrie Pharmaceutique Thieno[3,2-c]pyridine derivatives
EP1005864A1 (en) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Antioxidant free stable pharmaceutical compositions containing thienopyridine derivatives
US20050053660A1 (en) * 2001-01-31 2005-03-10 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051141A (en) * 1973-02-01 1977-09-27 Centre D'etudes Pour L'industrie Pharmaceutique Thieno[3,2-c]pyridine derivatives
EP1005864A1 (en) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Antioxidant free stable pharmaceutical compositions containing thienopyridine derivatives
US20050053660A1 (en) * 2001-01-31 2005-03-10 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007011473A1 *

Also Published As

Publication number Publication date
EP1901718A1 (en) 2008-03-26
WO2007011473A1 (en) 2007-01-25
DE112006001548T5 (en) 2008-04-30
ES2326251A1 (en) 2009-10-05
CA2611938A1 (en) 2007-01-25
ES2326251B1 (en) 2010-07-08

Similar Documents

Publication Publication Date Title
EP1951275A4 (en) ANTIOBESITY COMPOSITION
ITMI20041252A1 (en) PERFLUOROELASTOMERIC COMPOSITIONS
DE602006020996D1 (en) Enter HREREN
DK1965646T3 (en) Herbicide composition
EP1788047A4 (en) HYDROFUGE / OLEOFUGE COMPOSITION
DE602006000573D1 (en) Slide
DE602006020159D1 (en) HARDENABLE SILICONE COMPOSITION
EP1967540A4 (en) CURABLE COMPOSITION
EP1923431A4 (en) CURABLE COMPOSITION
NO20055686D0 (en) Composition
DE112006004277A5 (en) glass composition
DE502005004671D1 (en) Polyamide-EVA blends
DE602006012066D1 (en) THEREOF
ATE555657T1 (en) FUNGICIDE COMPOSITIONS
DE602006003113D1 (en) Aiguille à ponction guidee ultrasoniquement
DE602005016978D1 (en) Mercury-releasing compositions
EP1895348A4 (en) MICROSCOPE
DE602006006369D1 (en) developer compositions
DK1741339T3 (en) Pesticide composition
DE502006006590D1 (en) BIOZIDE COMPOSITIONS
DE602006000877D1 (en) emulsion composition
EP1970411A4 (en) CURABLE COMPOSITION
DE602006010127D1 (en) Curable composition
DE602005017191D1 (en) ODOR-REDUCED WASHPIECE COMPOSITION
DE502006001779D1 (en) ALLYLORGANOPOLYSILOXANE-BASED NETWORKABLE COMPOSITIONS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ELAN PHARMA INTERNATIONAL LIMITED

A4 Supplementary search report drawn up and despatched

Effective date: 20120620

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/26 20060101AFI20120614BHEP

Ipc: A61K 9/14 20060101ALI20120614BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130103